Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone to Prevent Post-Traumatic Osteoarthritis
NCT02318433Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2014
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexamethasone in Post-traumatic osteoarthritis (PTOA) (2 arms), sponsored by Mayo Clinic. Primary endpoint: Incidence of Post-Traumatic Osteoarthritis at 3 years. Started Dec 2014; status: completed.
02
Drugs
dexamethasone
03
Conditions
Post-traumatic osteoarthritis (PTOA)
Beyond the preview
Go deeper on NCT02318433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318433.